Variant report
Variant | nsv964145 |
---|---|
Chromosome Location | chr4:119356091-119359215 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs569226192 | chr4:119356146-119356147 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs3894444 | chr4:119356168-119356169 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs201627228 | chr4:119356210-119356211 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs558360341 | chr4:119356231-119356232 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs576850363 | chr4:119356250-119356251 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs539562463 | chr4:119356276-119356277 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs552692508 | chr4:119356282-119356283 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
8 | rs572753943 | chr4:119356288-119356289 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs3894291 | chr4:119356310-119356311 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
10 | rs541858230 | chr4:119356335-119356336 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs9684959 | chr4:119356343-119356344 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs561932997 | chr4:119356423-119356424 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs575634879 | chr4:119356432-119356433 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs544402568 | chr4:119356511-119356512 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs564344734 | chr4:119356518-119356519 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs192435340 | chr4:119356580-119356581 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs372164994 | chr4:119356581-119356582 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs547023931 | chr4:119356601-119356602 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs1809576 | chr4:119356603-119356604 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs1809575 | chr4:119356607-119356608 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs183263175 | chr4:119356630-119356631 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs143481176 | chr4:119356654-119356655 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
23 | rs548987430 | chr4:119356662-119356663 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs3879791 | chr4:119356668-119356669 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
25 | rs2077648 | chr4:119356680-119356681 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
26 | rs551674552 | chr4:119356721-119356722 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs187321509 | chr4:119356738-119356739 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs564491378 | chr4:119356749-119356750 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Acute lymphoblastic leukemia | 22237106 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Chordoma | 21602918 | CNVD |
HIV/AIDS | 22032296 | CNVD |
Medulloblastoma | 21979893 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Intellectual disability | 22102821 | CNVD |
Autism | 22495311 | CNVD |
Breast cancer | 21858162 | CNVD |
Small bowel adenocarcinoma | 21586687 | CNVD |
Gastric cancer | 21586687 | CNVD |
Basal cell lymphoma | 16317097 | CNVD |
Diffuse large b-cell lymphoma | 16317097 | CNVD |
Melanoma | 18172304 | CNVD |
Acute lymphoblastic leukemia | 20067559 | CNVD |
Breast cancer | 17603634 | CNVD |
Esophageal squamous carcinoma | 18350619 | CNVD |
Breast cancer | 16272173 | CNVD |
Colorectal cancer | 19359472 | CNVD |
Malignant mesothelioma | 18160781 | CNVD |
Medulloblastoma | 18056178 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Pleural malignant mesothelioma | 18160781 | CNVD |
Primary mediastinal b-cell lymphoma | 17728785 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
4q-syndrome | 17576883 | CNVD |
Cancer | 21637783 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Colorectal cancer | 20709793 | CNVD |
Muscular dystrophy | 21149563 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Breast cancer | 21264507 | CNVD |
Glioblastoma multiforme | 19960244 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Hepatocellular carcinoma | 22174799 | CNVD |
Liposarcoma | 21253554 | CNVD |
Oligodendroglial tumors | 17285580 | CNVD |
Cervical cancer | 21062161 | CNVD |
Metanephric adenoma | 20802469 | CNVD |
Breast cancer | 16608533 | CNVD |
Adenoid cystic carcinoma | 18698036 | CNVD |
Lung cancer | 19208797 | CNVD |
Wilms tumour | 21544195 | CNVD |
Breast cancer | 21785460 | CNVD |
Myelodysplastic syndrome | 21251322 | CNVD |
Lung cancer | 18438408 | CNVD |
Cancer | 22429812 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Cancer | 21183584 | CNVD |
primary effusion lymphomas | 17116491 | CNVD |
Splenic marginal zone lymphoma | 21957467 | CNVD |
Breast cancer | 17133270 | CNVD |
Colorectal cancer | 20459617 | CNVD |
High-grade prostatic intraepithelial neoplasia | 16573809 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Congenital anomalies of the kidney and urinary tract | 20505237 | CNVD |
Breast cancer | 17393978 | CNVD |
Esophageal cancer | 21851588 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Colorectal cancer | 16272173 | CNVD |
Testicular germ cell tumor | 18059402 | CNVD |
Ovarian cancer | 22174824 | CNVD |
Cutaneous T-cell lymphoma | 21881587 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Neuroblastoma | 21899760 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Renal cell carcinoma | 18194544 | CNVD |
Autism | 19246517 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Breast cancer | 22522925 | CNVD |
Pancreatic cancer | 17952125 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr4:119355000-119356200 | Enhancers | Adipose Derived Mesenchymal Stem Cell Cultured Cells | ES cell derived |
2 | chr4:119356000-119356800 | Enhancers | Fetal Muscle Leg | muscle |